History of poor tolerability to psychotropic drugs or drug interactions that increase risperidone plasma levels (see full labeling): may use lower initial dose of 12.5mg.

Risperidone 0.5mg, 1mg, 2mg, 3mg, 4mg; contains phenylalanine. Initially 2–3mg once daily; may adjust at intervals of at least 24hrs by 1mg/day. Usual range: 1–6mg/day; max 6mg/day. Elderly ...

Medindia neither buys nor sells drugs. Risperidone (Risnia (2 mg)) is an atypical antipsychotic, prescribed for Asperger's syndrome (difficulties in social interaction), schizophrenia (disturbed ...

Antipsychotic drug trials that specifically address the ... 6 weeks); and to compare the anti-hallucinatory effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone with up to 2 ...

carbamazepine, a drug mainly used for epilepsy or trigeminal neuralgia (severe pain attacks in the face) may decrease the level of risperidone in your blood. medicines to treat depression ...

Find all the commercial and brand names of generic drug called Risperidone. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

ValiSeek has combined the ingredient risperidone and rumenic acid in a patent-protected gelatin-capsule formulation, VAL401, for oral delivery. The drug reduces cellular activity in many different ...

Four children who were allegedly “over-medicated” after being referred to South Kerry Child and Adolescent Mental Health ...

If a daily total oral dose of at least 2mg is well tolerated (i.e. the drug does not upset you), an injection of RISPERDAL CONSTA can be administered every 2 weeks. It is very important to keep ...

Summary: Risperidone is the first atypical antipsychotic available in a long-acting injectable formulation. After a single injection, significant plasma levels of the drug are achieved at week 3 ...

The settlements against the HSE were reached after mediation. Four children who it was claimed were "over medicated" after ...

Lyndra Therapeutics has announced positive results from the Phase III STARLYNG-1 (LYN-005-C-301) clinical trial of oral weekly dose of risperidone (LYN-005) to treat schizophrenia and ...